Details of the Drug Combinations

General Information of This Drug (ID: DMF0NA9)

Drug Name

KX-01 DMF0NA9

Indication

Disease Entry	ICD 11	Status	REF
Actinic keratosis	EK90.0	Phase 3	[1]
------------------------------------------------------------------------------------

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
KX-01 + Idarubicin	DC54TL2	Idarubicin	Glioblastoma? (Cell Line: T98G)	[2]
------------------------------------------------------------------------------------

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Paclitaxel + KX-01	DCYEUFH	Paclitaxel	Solid tumour/cancer	[3]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3	Clinical pipeline report, company report or official report of Kinex Pharmaceuticals.